Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has announced its participation in the H.C. Wainwright Global Investment Conference in New York City on September 10, 2024. The company is scheduled to give a corporate presentation at 2:00 p.m. Eastern Time. Investors can access the live presentation through Vanda's corporate website, www.vandapharma.com, by navigating to the Investors tab and following the link under Recent Events.
Attendees are advised to arrive at the conference website 15 minutes early to register and set up any necessary software. The archived presentation will be available on Vanda's website for approximately 30 days after the event.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha annunciato la sua partecipazione alla H.C. Wainwright Global Investment Conference a New York il 10 settembre 2024. L'azienda è programmata per una presentazione aziendale alle 14:00 ora orientale. Gli investitori possono accedere alla presentazione dal vivo attraverso il sito web aziendale di Vanda, www.vandapharma.com, navigando alla sezione Investitori e seguendo il link sotto Eventi Recenti.
Si consiglia agli partecipanti di accedere al sito della conferenza 15 minuti prima per registrarsi e configurare eventuali software necessari. La presentazione registrata sarà disponibile sul sito di Vanda per circa 30 giorni dopo l'evento.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) ha anunciado su participación en la H.C. Wainwright Global Investment Conference en Nueva York el 10 de septiembre de 2024. La compañía está programada para hacer una presentación corporativa a las 2:00 p.m., hora del Este. Los inversores pueden acceder a la presentación en vivo a través del sitio web corporativo de Vanda, www.vandapharma.com, navegando a la pestaña de Inversores y siguiendo el enlace en Eventos Recientes.
Se aconseja a los asistentes que lleguen al sitio de la conferencia 15 minutos antes para registrarse y configurar cualquier software necesario. La presentación grabada estará disponible en el sitio de Vanda durante aproximadamente 30 días después del evento.
반다 제약 주식회사(Nasdaq: VNDA)가 H.C. 웨인라이트 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 이 행사 는 뉴욕에서 2024년 9월 10일에 열립니다. 회사는 동부 표준시로 오후 2시에 기업 발표를 진행할 예정입니다. 투자자들은 반다의 기업 웹사이트 www.vandapharma.com을 통해 실시간 발표에 접속할 수 있으며, 투자자 탭으로 이동하여 최근 이벤트 아래 링크를 따라가면 됩니다.
참석자들은 등록하고 필요한 소프트웨어를 설정하기 위해 컨퍼런스 웹사이트에 15분 일찍 도착할 것을 권장합니다. 기록된 발표는 이벤트 후 약 30일간 반다 웹사이트에서 이용할 수 있습니다.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) a annoncé sa participation à la H.C. Wainwright Global Investment Conference à New York le 10 septembre 2024. L'entreprise doit donner une présentation corporative à 14h00, heure de l'Est. Les investisseurs peuvent accéder à la présentation en direct via le site Web de Vanda, www.vandapharma.com, en naviguant vers l'onglet Investisseurs et en suivant le lien sous Événements récents.
Il est conseillé aux participants d'arriver 15 minutes à l'avance sur le site de la conférence pour s'enregistrer et configurer tout logiciel nécessaire. La présentation enregistrée sera disponible sur le site de Vanda pendant environ 30 jours après l'événement.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) hat seine Teilnahme an der H.C. Wainwright Global Investment Conference in New York City am 10. September 2024 bekannt gegeben. Das Unternehmen wird für eine Unternehmenspräsentation um 14:00 Uhr Eastern Time eingeplant. Anleger können die Live-Präsentation über die Unternehmenswebsite von Vanda, www.vandapharma.com, abrufen, indem sie zur Investorenseite navigieren und dem Link unter Aktuelle Ereignisse folgen.
Teilnehmern wird geraten, 15 Minuten früher auf der Konferenzseite zu erscheinen, um sich zu registrieren und notwendige Software einzurichten. Die archivierte Präsentation wird etwa 30 Tage nach der Veranstaltung auf Vandas Website verfügbar sein.
- None.
- None.
The corporate presentation given at the H.C. Wainwright Global Investment Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-hc-wainwright-global-investment-conference-302238618.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When and where is Vanda Pharmaceuticals (VNDA) presenting at the H.C. Wainwright Global Investment Conference?
How can investors access Vanda Pharmaceuticals' (VNDA) presentation at the H.C. Wainwright conference?
How long will the archived version of Vanda Pharmaceuticals' (VNDA) conference presentation be available?
